Matthew Foster and Tarric Sookdeo break down how traders use Public’s API to validate risk, automate complex options strategies, and scale execution with confidence. Watch now. 'The damage has been ...

Mercer County Sheriff Doug Timmerman recently donated his kidney to a total stranger. Republican warns Trump admin move "disastrous" for security 3 major revelations about President Donald Trump in ...

BSCScan APIs have been deprecated, developers were forced to shift to Etherscan which provided paid access. BSCTrace was introduced as an alternative to BSCScan. Developers regain stability and lower ...

Legacy Python packages contain vulnerable bootstrap scripts that can enable domain takeover attacks on PyPI. The vulnerable bootstrap scripts fetch installation files from a now-available domain used ...

Relay, the multichain payments and liquidity network, announces the addition of the TRON network to its multichain platform, including API and flagship App. The integration will allow developers and ...

Investors in Rivian Automotive Inc (Symbol: RIVN) saw new options begin trading today, for the January 2026 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the RIVN ...

Investors in Jumia Technologies AG (Symbol: JMIA) saw new options become available today, for the January 2026 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

In some ways, Java was the key language for machine learning and AI before Python stole its crown. Important pieces of the data science ecosystem, like Apache Spark, started out in the Java universe.

I received an email from IB saying there will be change in API: "Due to an external SEC rule update (RIN 3235-AN23), we are required to enforce a change in the round lot sizes of US stock that will ...

Join us for an exclusive webinar where we unveil our new Python API designed to streamline trading as a price taker in FX Options. Whether you are a seasoned quant or trader looking to incorporate ...

Big pharmaceutical companies are boosting their production capacity of branded medications with billions of dollars in new U.S. manufacturing plant construction, but generic drug production still ...